79 results
6-K
EX-99.1
THTX
Theratechnologies Inc.
10 Apr 24
Interim Consolidated Financial Statements
8:30am
arrangements and warrant liabilities, which are measured at fair value. Equity-classified shared-based payment arrangements are measured at fair … warrant, a “Public Offering Warrant”) and is classified in Share Capital and Public Offering Warrants within equity. During the first quarter ended
6-K
EX-99.1
THTX
Theratechnologies Inc.
21 Feb 24
Theratechnologies Reports Financial Results
8:00am
activities, which were previously classified as cash flow from financing activities and interest received as cash flows from investing activities.
During
F-3
THTX
Theratechnologies Inc.
21 Dec 23
Shelf registration (foreign)
1:21pm
to Investissement Québec as part of the Concurrent Private Placement, as the Exchangeable Subscription Receipts are equity-classified.
The applicable … as at August 31, 2023, was classified as a current liability as at such date due to a breach of the Marathon Credit Agreement that was unwaived
6-K
EX-99.1
THTX
Theratechnologies Inc.
26 Oct 23
Current report (foreign)
9:15pm
of the Offered Shares and the nature of the Company’s business, the Company does not expect to be classified as a PFIC for the taxable year ending November 30 … to be classified as a CFC for the taxable year ending November 30, 2023.
(bbb) Choice of Law. The Company has the power to designate, appoint
SUPPL
2062ir1a
26 Oct 23
Supplemental materials (foreign)
9:13pm
SUPPL
4p3ki10m3riofze3x50
25 Oct 23
Supplemental materials (foreign)
6:56pm
6-K
EX-99.1
bxi69cy69
26 Sep 23
Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
8:02am
6-K
EX-99.1
wngi0rgfktc2eff3v mz
26 Sep 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.2
1vzmr4z61d19ry8qx
26 Sep 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.2
6mkg16a
12 Jul 23
Interim Consolidated Financial Statements
8:02am
6-K
EX-99.1
88mr8tx gjqmoe
12 Jul 23
Interim Consolidated Financial Statements
8:02am
6-K
EX-99.1
hquwwj6dk1z0ox8
12 Jul 23
Theratechnologies Reports Second Quarter 2023
8:00am
6-K
EX-99.1
46ljg
12 Apr 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.2
lhh6o1g
12 Apr 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.1
qo9c687uq6aom598hhj
12 Apr 23
Theratechnologies Reports Financial Results and Business Updates for First Quarter 2023
7:45am
6-K
EX-99.1
y3ixl95v5 gi61
13 Oct 22
Interim Consolidated Financial Statements
8:01am
6-K
EX-99.2
xba6 ca80m63voyjeb9
21 Jul 22
Material Change Report
4:40pm
6-K
EX-99.1
m2t4p
14 Jul 22
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.1
r0dv8l1pwhjrkl
13 Apr 22
Interim Consolidated Financial Statements
7:45am